NCT05662085View on ClinicalTrials.gov

Progression Rate of Pseudoxanthoma Elasticum-associated Choroidal and Retinal Degeneration

Active, not recruitingOBSERVATIONAL

Enrollment

25

Participants

Timeline

Start Date

October 1, 2022

Primary Completion Date

October 31, 2025

Study Completion Date

October 31, 2025

Conditions

Pseudoxanthoma Elasticum

Interventions

OTHER

No intervention

According to clinical practice.

Trial Locations (1)

CH-4031

University Hospital Basel, Basel

All Listed Sponsors

lead

University Hospital, Basel, Switzerland

OTHER